Brief: Biophytis: Start Of Patient Recruitment For Part 2 Of Phase 2-3 COVA Trial

Biophytis SA

03/02/2021 07:04

Feb 3 (Reuters) - Biophytis SA  ALBPS.PA :
    * BIOPHYTIS ANNOUNCES THE START OF PATIENT RECRUITMENT IN
BRAZIL
AND THE USA FOR PART 2 OF THE PHASE 2-3 COVA TRIAL (“COVA
STUDY”)
    * PATIENT RECRUITMENT IN PART 2 OF COVA STUDY WILL BEGIN IN
MOST
CLINICAL CENTERS IN BRAZIL AND UNITED STATES
    * INTERIM ANALYSIS OF PART 1 IS EXPECTED IN Q1 2021
    * RESULTS FROM FULL STUDY (PART 1 AND PART 2) ARE EXPECTED
IN Q2
2021
    * PATIENT RECRUITMENT AT MOST CLINICAL CENTERS IN BRAZIL AND
UNITED STATES WILL BEGIN FOR PART 2 OF ITS COVA STUDY ASSESSING
SARCONEOS (BIO101) AS POTENTIAL TREATMENT FOR ACUTE RESPIRATORY
FAILURE ASSOCIATED WITH COVID-19

Source text for Eikon:  ID:nGNXb1DBM1 
Further company coverage:  ALBPS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))